Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response

Virology

Volumn 269, Issue 2, 2000, Pages 383-390

  Young, D F ^a   Didcock, L ^a   Goodbourn, S ^b   Randall, R E ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Interferon; Paramyxoviruses; STAT1; STAT2

Indexed keywords

INTERFERON; STAT1 PROTEIN; STAT2 PROTEIN;

ARTICLE; HOST RESISTANCE; IMMUNOMODULATION; INTERFERON PRODUCTION; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SENDAI VIRUS; SIGNAL TRANSDUCTION; SIMIAN VIRUS; TRANSCRIPTION REGULATION; VIRUS RESISTANCE;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; PARAMYXOVIRIDAE; PARAMYXOVIRINAE; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES; SENDAI VIRUS; SIMIAE; SIMIAN PARAINFLUENZA VIRUS 5; SIMIAN VIRUS; SYNCYTIAL VIRUS;

EID: 0034630371     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0240     Document Type: Article

References (27)

1. Atreya P. L., Kulkarni S. Respiratory syncytial virus A2 is resistant to the antiviral effects of type I interferons and human MxA. Virology. 261:1999;227-241.
2. Chin Y. E., Kitagawa M., Kuida K., Flavell R. A., Fu X. Y. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 17:1997;5328-5337.
3. Choppin P. W. Multiplication of a myxovirus (SV5) with minimal cytopathic effects and without interference. Virology. 23:1964;224-233.
4. Collins P. L., McIntosh K., Chanock R. M. Respiratory syncytial virus. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;1313-1351 Raven Press, New York.
5. Didcock L., Young D. F., Goodbourn S., Randall R. E. Sendai virus and simian virus 5 block activation of interferon-responsive genes: Importance for virus pathogenesis. J. Virol. 73:1999a;3125-3133.
6. Didcock L., Young D. F., Goodbourn S., Randall R. E. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J. Virol. 73:1999b;9928-9933.
7. Garcin D., Latorre P., Kolakofsky D. Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J. Virol. 73:1999;6559-6565.
8. Goswami K. K. A., Russell W. C. Monoclonal antibodies against human paramyxovirus type 3 and against SV5: Preparation and preliminary characterisation. J. Gen. Virol. 64:1983;1663-1672.
9. King P., Goodbourn S. The β-interferon promoter responds to priming through multiple independent regulatory elements. J. Biol. Chem. 269:1994;30609-30615.
10. King P., Goodbourn S. STAT1 is inactivated by a caspase. J. Biol. Chem. 273:1998;8699-8704.
11. Lamb R. A., Kolakofsky D. Paramyxoviridae: The viruses and their replication. Fields B. N., Knipe D. M., Howley P. M. Virology. 1996;1177-1204 Lippincott-Raven Press, New York.
12. Masson N., Ellis M., Goodbourn S., Lee K. A. W. Cyclic-AMP response-binding protein and the catalytic subunit of protein kinase A are present in F9 embryonal carcinoma cells but are unable to activate the somatostatin promoter. Mol. Cell. Biol. 12:1992;1096-1102.
13. Muller M., Laxton C., Briscoe J., Schindler C., Improta T., Darnell J. E Jr., Stark G. R, Kerr I. M. Complementation of a mutant cell line: Central role of the 91 kDa polypeptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J. 12:1993;4221-4228.
14. Pamer E., Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:1998;323-358.
15. Pellegrini S., Shearer J. J., Kerr I. M., Stark G. R. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9:1989;4605-4612.
16. Ploegh H. L. Viral strategies of immune evasion. Science. 280:1998;248-253.
17. Randall R. E., Dinwoodie N. Intranuclear localisation of herpes simplex virus immediate-early and delayed-early proteins. Evidence that ICP4 is associated with progeny virus DNA. J. Gen. Virol. 67:l986;2l63-2177.
18. Randall R. E., Young D. F. Comparison between parainfluenza virus type 2 and simian virus 5: Monoclonal antibodies reveal major antigenic differences. J. Gen. Virol. 69:1988;2051-2060.
19. Randall R. E., Young D. F., Goswami K. K.A, Russell W. C. Isolation and characterisation of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates. J. Gen. Virol. 68:1987;2769-2780.
20. Rehberg E., Kelder B., Hoal E. G., Pestka S. Specific molecular activities of recombinant and hybrid interferons. J. Biol. Chem. 257:1982;11497-11502.
21. Rima B., Alexander D. J., Bileter M. A., Collins P. L., Kingsbury D. W., Lipkind M. A., Nagai Y., Orvell C., Pringle C. R. Paramyxoviridae. Murphy F. A., Fauquest C. M., Bishop D. H. L., Ghabrial S. A., Jarvis A. W., Martelli G. P., Mayo M. A., Summers M. D. Virus Taxonomy. 1995;Springer-Verlag, Vienna, New York.
22. Seow H. F. Pathogen interactions with cytokines and host defence: An overview. Vet. Immunol. Immunopathol. 63:1998;139-148.
23. Smith G. L. Virus strategies for evasion of the host response to infection. Trends Microbiol. 2:1994;81-88.
24. Stark G. R., Kerr I. M., Williams B. R. G., Silverman R. H., Schreiber R. D. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264.
25. Thomas N. S., Pizzey A. R., Tiwari S., Williams C. D., Yang J. p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon. J. Biol. Chem. 273:1998;23659-23667.
26. Whiteside S. T., Visvanathan K. V., Goodbourn S. Identification of novel factors that bind to the PRD I region of the human β-interferon promoter. Nucleic Acids Res. 20:1992;1531.
27. Yokosawa N., Kubota T., Fujji N. Poor induction of interferon induced 2′, 5′-oligoadenylate synthetase (2-5 AS) in cells persistently infected with mumps virus is caused by decrease of STAT-1 alpha. Arch. Virol. 143:1998;1985-1992.